Newly synthetic ceramide-1-phosphate analogs; their uptake, intracellular localization, and roles as an inhibitor of cytosolic phospholipase A(2)α and inducer of cell toxicity.
Ceramide-1-phosphate (C1P) regulates cellular functions including arachidonic acid (AA) metabolism and modulates cell fate. The mechanism by which C1P is taken up is unclear, and the development of lipophilic analogs may be useful for regulating C1P's actions. We synthesized new mono- and di-methyl-ester (MM and DM, respectively) analogs of C1P with N-acyl chains of different lengths, and examined their effects on AA release and cell toxicity. Short-N-acyl-DM-C1P analogs including C5- and C6-DM-C1P, but not long-N-acyl-DM-C1P analogs, inhibited the release of AA mediated by α type cytosolic phospholipase A(2) (cPLA(2)α) in Chinese hamster ovary (CHO) cells and the enzymatic activity. Short-N-acyl-DM-C1P analogs including C6-DM-C1P caused morphological changes with cell toxicity 24h after the treatment in three cells lines (CHO, L929, and RLC-18 cells), although the role of AA in the toxicity was not clear. Neither long-N-acyl-DM-C1P analogs nor MM-C1P analogs including C6-MM-C1P affected cPLA(2)α activity and cell toxicity. Similar to C6-ceramide having a 4-nitrobenzo-2-oxa-1,3-diazole (NBD) group on a C6-N-acyl chain (NBD-C6-ceramide), NBD-C6-DM-C1P and C6-DM-C1P-NBD (with a C6-N-acyl chain and an NBD-labeled C14-alkyl chain) were accumulated in the Golgi complex, although less C6-DM-C1P-NBD than NBD-C6-DM-C1P was taken up. NBD-C6-ceramide was converted to various metabolites including NBD-C6-sphingomyelin, but both NBD-C6-DM-C1P and C6-DM-C1P-NBD were stable in cells within 2h. The short-N-acyl-DM-C1P analogs acted directly as an inhibitor of cPLA(2)α and an inducer of cell toxicity, and may be useful for the regulation of ceramide/C1P-regulated responses.
Makiyama
Tomohiko
T
Chiba University, Inohana, Chuo-ku, Japan.
Nagasaka
Nobuo
N
Houjyo
Yuuya
Y
Yamaura
Erika
E
Nakamura
Hiroyuki
H
Koide
Yuuki
Y
Nishida
Atsushi
A
Murayama
Toshihiko
T
D000818:Animals; D016718:Arachidonic Acid / Q000378:metabolism; D001692:Biological Transport; D016466:CHO Cells; D016923:Cell Death / Q000187:drug effects; D002518:Ceramides / Q000493:pharmacokinetics* / Q000494:pharmacology*; D006224:Cricetinae; D003412:Cricetulus; D054513:Group IV Phospholipases A2 / Q000037:antagonists & inhibitors* / Q000502:physiology; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D013329:Structure-Activity Relationship
D002518:Ceramides; C065576:ceramide 1-phosphate; D016718:Arachidonic Acid; D007770:L-Lactate Dehydrogenase; D054513:Group IV Phospholipases A2